Jakafi (ruxolitinib) Approved to Treat Myelofibrosis
New Drugs , News / September 27, 2016

Jakafi (ruxolitinib) is now the first drug to be approved by the FDA for the treatment of patients with the bone marrow disease known as myelofibrosis. Myelofibrosis is a disease in which the bone marrow is replaced by scar tissue resulting in blo...

Skip to toolbar